VeriGraft
PrivateLast Round
VC Round
Feb 12, 2026
Est. Valuation
$32.63M
Total Funding Raised
$2.44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VeriGraft is a biotechnology company that develops personalized tissue-engineered grafts for transplantation and tissue replacement.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VeriGraft Comparables
Compare VeriGraft with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascudyne | 79% | |
| enVVeno Medical Corporation | 77% | |
| Humacyte | 77% |
VeriGraft Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 12, 2026 | ||||
| Crowdfunding | Mar 14, 2025 | ||||
| Grant | Feb 13, 2025 | ||||
| Grant | Dec 18, 2024 | ||||
| Grant | Nov 1, 2017 |
Key People
Founding team and executive leadership
VeriGraft Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Vinnova | Grant |
| Horizon Europe | Grant |
| Capital Cell | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2026
$12.3M raised in a VC Round.
- Jun 1, 2025
Monthly visitors grew 297% MoM, from 109 to 433.
VeriGraft Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VeriGraft's valuation, stock price, and market status.
Is VeriGraft a public or private company?
VeriGraft is a private company.
What is the current stock price of VeriGraft?
VeriGraft is a private company, so its shares have no public market price. Caplight tracks VeriGraft's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VeriGraft worth (valuation)?
VeriGraft's valuation is estimated at $32.6M based on funding round data.
Can I buy VeriGraft stock?
VeriGraft shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VeriGraft's last funding round?
VeriGraft's most recent funding round was VC Round on February 12, 2026.
Who are the main investors in VeriGraft?
Key investors in VeriGraft include Eurostars SME programme, Vinnova, Horizon Europe, Capital Cell.
Will VeriGraft IPO soon?
No public IPO plans have been announced for VeriGraft.
How can I track VeriGraft secondary market activity?
Caplight tracks bids, offers, and trades in VeriGraft's shares on secondary markets.